Startup Observer.com
  • Home
  • Industries
  • Innovation
  • outsourcing
  • Business
  • Finance
  • Headlines
  • Opinion
  • News
Home News Spacing Pfizer COVID shots boosts antibody levels in long-term study
News

Spacing Pfizer COVID shots boosts antibody levels in long-term study

by jcp July 23, 2021
July 23, 2021
gawdo

LONDON (Reuters) -A longer gap between doses of Pfizer’s COVID-19 vaccine leads to higher overall antibody levels than a shorter gap, a British study found on Friday, but antibody levels are not sustained for long after the first dose.

The study might help inform vaccination strategies against the Delta variant, which reduces the effectiveness of a first dose of the vaccine even though two doses are still protective, and one author said that Britain’s eight-week gap was a “sweet spot” against Delta.

The authors emphasised that either dosing schedule produced a strong antibody and T-cell response in the study of 503 healthcare workers.

“For the longer dosing interval … neutralising antibody levels against the Delta variant were poorly induced after a single dose, and not maintained during the interval before the second dose,” the authors of the study, which is being led by the University of Oxford, said.

“Following two vaccine doses, neutralising antibody levels were twice as high after the longer dosing interval compared with the shorter dosing interval.”

Neutralising antibodies are thought to play an important role in immunity against the coronavirus, but are not the whole picture, with T-cells also playing a part.

The study found overall T-cell levels were 1.6 times lower with a long gap compared with the short dosing interval of 3-4 weeks, but that a higher proportion were “helper” T-cells, which support long-term immune memory, with the long gap.

“While we tend to emphasise neutralising antibodies as a measure of the immune response … cellular immunity, which is harder to measure, is also likely to be very important,” said Peter English, former chair of the BMA Public Health Medicine Committee.

The findings, issued as a pre-print, support the view that, while a second dose is needed to provide full protection against Delta, delaying that dose might provide more durable immunity, even if it is at the cost of protection in the short-term.

Last December, Britain extended the interval between vaccine doses to 12 weeks, although Pfizer warned there was no evidence to support a move away from a three-week gap.

Britain now recommends an eight-week gap between vaccine doses to give more people high protection against Delta more quickly, while still maximising immune responses in the longer term.

“I think the eight-week (interval) is about the sweet spot,” Susanna Dunachie, joint chief investigator on the study, told reporters.

(Reporting by Alistair Smout; Editing by Giles Elgood)

 

www.gawdo.com
Share on FacebookShare on TwitterShare on Linkedin
0 FacebookTwitterPinterestEmail
previous post
Contact Centre Absenteeism: More Flexibility is the Cure
next post
U.S. stock markets, treasury yields perk up, oil falters as choppy week winds down

You may also like

Open University to focus on societal challenges that...

June 23, 2022

Aramco and Cognite join forces in new data...

June 22, 2022

Sponsors Announced for Biggest Ever Summer School for...

June 20, 2022
Editorial & Advertiser disclosureEditorial & Advertiser disclosureOur website provides you with information, news, press releases, Opinion and advertorials on various financial products and services. This is not to be considered as financial advice and should be considered only for information purposes. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third party websites, affiliate sales networks, and may link to our advertising partners websites. Though we are tied up with various advertising and affiliate networks, this does not affect our analysis or opinion. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you, or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish sponsored articles or links, you may consider all articles or links hosted on our site as a partner endorsed link.
gawdo.com
https://www.gawdo.com
  • About us
  • Advertising & Terms of Use
  • Contact Us
  • Privacy Policy

@2021 - All Right Reserved.


Back To Top
Startup Observer.com
  • Home
  • Industries
  • Innovation
  • outsourcing
  • Business
  • Finance
  • Headlines
  • Opinion
  • News
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT